$CPRX CATALYST PHARMACEUTICALS, INC. Insider Trading
Get free email notifications about insider trading in CATALYST PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CATALYST PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in CATALYST PHARMACEUTICALS, INC. for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CPRX
Company Address: 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES 33134
Former name: Catalyst Pharmaceutical Partners, Inc., date of change: 2006-07-19
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
Market Capitalization: $92.81M
Prev close: $1.13
Average Daily Volume: 532,266
Days Low: $1.11
Year Low: $0.51
Year High: $1.93
CATALYST PHARMACEUTICALS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 3.42 | 30,000 | 102,600 | 356,167 | |
| Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 3.42 | 30,000 | 102,600 | 356,167 | |
| Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 3.42 | 275,000 | 940,500 | 1,590,000 | |
| Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 3.42 | 400,000 | 1,368,000 | 3,551,667 | |
| Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 3.42 | 200,000 | 684,000 | 1,071,334 | |
| Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 3.42 | 250,000 | 855,000 | 1,491,334 | |
| Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | Elsbernd Brian | Chief Compliance/Le ... | Option Exercise | A | 3.42 | 200,000 | 684,000 | 801,334 | |
| Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 3.42 | 30,000 | 102,600 | 356,167 | |
| Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | Del Carmen Jeffrey | Chief Commercial Of ... | Option Exercise | A | 3.42 | 200,000 | 684,000 | 600,000 | |
| Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 3.42 | 30,000 | 102,600 | 356,167 | |
| Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 3.42 | 30,000 | 102,600 | 356,167 | |
| Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | M | 0.00 | 14,666 | 0 | 871,334 | |
| Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Sell | S | 3.45 | 3,668 | 12,644 | 10,998 | 14.7 K to 11 K (-25.01 %) |
| Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Buy | M | 0.00 | 14,666 | 0 | 14,666 | 0 to 14.7 K |
| Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | M | 0.00 | 14,666 | 0 | 871,334 |
View all CATALYST PHARMACEUTICALS, INC. insider transactions.